FIA
PLSE icon

FNY Investment Advisers’s Pulse Biosciences PLSE Stock Holding History

FNY Investment Advisers’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-86
Closed -$1K – 1353
2025
Q3 		$1K Buy
+86
New +$1.36K ﹤0.01% 1171

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

FNY Investment Advisers's PLSE Position: Q4 2025 in Review

FNY Investment Advisers sold out of Pulse Biosciences (PLSE) in Q4 2025, closing a stake of 86 shares — an estimated $1K sold.

FNY Investment Advisers first reported a position in PLSE in Q3 2025 and held it in 1 quarter. The position peaked at $1K in Q3 2025. 82 funds tracked by Wall St. Rank hold PLSE as of Q4 2025.

  • FNY Investment Advisers reported no remaining Pulse Biosciences position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 86 Pulse Biosciences shares in Q4 2025, an estimated $1K.
  • FNY Investment Advisers first reported a position in Pulse Biosciences in Q3 2025 and held it in 1 quarter.
  • FNY Investment Advisers's Pulse Biosciences position peaked at $1K in Q3 2025.
  • 82 funds tracked by Wall St. Rank held Pulse Biosciences as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.